Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLAC Bellevue Life Sciences Acquisition	$0.60 -2.4%	$1.17	$3.01 ▼ $13.40	$2.44M	-0.08	22,626 shs	77,807 shs
CODX Co-Diagnostics	$0.27 +0.9%	$0.27	$0.23 ▼ $2.23	$8.91M	0.51	472,510 shs	820,568 shs
ICU SeaStar Medical	$0.88 +21.0%	$0.74	$0.31 ▼ $6.90	$9.86M	-1.04	3.28 million shs	4.42 million shs
LUCY Innovative Eyewear	$2.20 +10.0%	$2.24	$1.57 ▼ $11.16	$10.07M	3.21	1.28 million shs	313,458 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLAC Bellevue Life Sciences Acquisition	0.00%	-7.80%	-48.82%	-50.09%	-94.48%
CODX Co-Diagnostics	+2.48%	+3.38%	-1.96%	-14.81%	-77.78%
ICU SeaStar Medical	0.00%	-8.86%	+30.36%	-41.13%	-87.97%
LUCY Innovative Eyewear	+1.52%	+2.04%	-6.98%	-28.32%	-50.98%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BLAC Bellevue Life Sciences Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CODX Co-Diagnostics	4.2893 of 5 stars	3.5	3.0	0.0	4.4	3.3	0.0	1.3
ICU SeaStar Medical	0.9369 of 5 stars	0.0	5.0	0.0	0.0	1.9	1.7	0.0
LUCY Innovative Eyewear	0.3355 of 5 stars	0.0	2.0	0.0	0.0	2.8	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLAC Bellevue Life Sciences Acquisition	0.00	N/A	N/A	N/A
CODX Co-Diagnostics	3.00	Buy	$5.50	1,972.34% Upside
ICU SeaStar Medical	0.00	N/A	N/A	N/A
LUCY Innovative Eyewear	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLAC Bellevue Life Sciences Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
CODX Co-Diagnostics	$3.91M	2.28	N/A	N/A	$1.70 per share	0.16
ICU SeaStar Medical	$428K	23.04	N/A	N/A	($0.34) per share	-2.59
LUCY Innovative Eyewear	$1.71M	5.89	N/A	N/A	$3.72 per share	0.59

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLAC Bellevue Life Sciences Acquisition	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
CODX Co-Diagnostics	-$37.64M	-$1.17	N/A	N/A	N/A	-1,025.45%	-60.16%	-52.69%	8/14/2025 (Estimated)
ICU SeaStar Medical	-$24.83M	-$2.62	N/A	∞	N/A	N/A	N/A	-313.28%	N/A
LUCY Innovative Eyewear	-$7.77M	-$3.99	N/A	∞	N/A	-443.18%	-86.90%	-81.36%	8/18/2025 (Estimated)

Latest BLAC, ICU, LUCY, and CODX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	CODX Co-Diagnostics	-$0.25	N/A	N/A	N/A	$0.30 million	N/A
8/13/2025	Q2 2025	ICU SeaStar Medical	-$0.43	-$0.18	+$0.25	-$0.18	$0.25 million	$0.34 million
5/14/2025	Q1 2025	ICU SeaStar Medical	-$0.52	-$0.44	+$0.08	-$0.44	$0.15 million	$0.29 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLAC Bellevue Life Sciences Acquisition	N/A	N/A	N/A	N/A	N/A
CODX Co-Diagnostics	N/A	N/A	N/A	N/A	N/A
ICU SeaStar Medical	N/A	N/A	N/A	N/A	N/A
LUCY Innovative Eyewear	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLAC Bellevue Life Sciences Acquisition	N/A	N/A	N/A
CODX Co-Diagnostics	N/A	4.43	4.23
ICU SeaStar Medical	N/A	0.96	0.96
LUCY Innovative Eyewear	N/A	16.40	13.02

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BLAC Bellevue Life Sciences Acquisition	55.30%
CODX Co-Diagnostics	14.99%
ICU SeaStar Medical	1.69%
LUCY Innovative Eyewear	0.96%

Insider Ownership

Company	Insider Ownership
BLAC Bellevue Life Sciences Acquisition	33.67%
CODX Co-Diagnostics	8.40%
ICU SeaStar Medical	1.30%
LUCY Innovative Eyewear	1.66%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BLAC Bellevue Life Sciences Acquisition	N/A	4.04 million	2.68 million	Not Optionable
CODX Co-Diagnostics	100	33.57 million	30.75 million	Optionable
ICU SeaStar Medical	2	11.20 million	11.06 million	Not Optionable
LUCY Innovative Eyewear	9	4.58 million	4.50 million	Not Optionable

BLAC, ICU, LUCY, and CODX Headlines

Recent News About These Companies

Innovative Eyewear Announces Participation in Key Industry and Investor Events in Q3 2025

August 11 at 8:00 AM | prnewswire.com

Innovative Eyewear Launches Reebok Smartglasses in New Channels

July 21, 2025 | prnewswire.com

Innovative Eyewear, Inc. (LUCY) - Yahoo Finance

July 13, 2025 | finance.yahoo.com

Innovative Eyewear, Inc. Announces Closing of Exercise of Warrants

June 24, 2025 | prnewswire.com

Innovative Eyewear, Inc. Announces $4.8 Million of Gross Proceeds Raised from Warrant Transactions

June 23, 2025 | prnewswire.com

Innovative Eyewear stock soars after partnership with Smartech Retail

June 20, 2025 | investing.com

Innovative Eyewear Partners with Smartech to Showcase Reebok Smart Eyewear at Smartech's New Flagship Opening in Times Square

June 20, 2025 | prnewswire.com

Innovative Eyewear, Inc. Announces Exciting New Features for the Lucyd ChatGPT App

May 29, 2025 | prnewswire.com

Innovative Eyewear, Inc.: Innovative Eyewear Inc. Reports Q1 2025 Unaudited Financial Results

May 14, 2025 | finanznachrichten.de

Better-Than-Expected Q1 Sales Propelled This Penny Stock On Wednesday

May 14, 2025 | msn.com

Innovative Eyewear Inc. Reports Q1 2025 Unaudited Financial Results

May 13, 2025 | prnewswire.com

Innovative Eyewear Partners with Eye Recommend, Expanding Smart Eyewear Access Across 600+ Independent Optometry Stores

May 5, 2025 | finance.yahoo.com

Innovative Eyewear, Eye Recommend partner to supply 600+ clinics in Canada

May 5, 2025 | msn.com

Innovative Eyewear Launches Reebok® Smart Eyewear

April 28, 2025 | prnewswire.com

Innovative Eyewear launches Reebok ChatGPT glasses with Micah Richards

April 28, 2025 | proactiveinvestors.co.uk

Innovative Eyewear, Inc. Highlights Smart Eyewear Competitive Pricing Edge Amid Eyeglass Industry Cost Pressures Due to Tariffs

April 23, 2025 | prnewswire.com

Innovative Eyewear, Inc. Announces Exercise of Warrants for $1.8 Million Gross Proceeds

April 11, 2025 | prnewswire.com

How Lucyd Eyewear Is Enhancing How We All Wear Eyeglasses

April 10, 2025 | cheddar.comC

Eyewear Update: Lucyd Armor Opens European Doors, Moonbeam Adds Everyday Appeal

April 10, 2025 | techacute.comT

Innovative Eyewear enters EU market, receives EU Certification for Lucyd Armor Safety Glasses

April 10, 2025 | prnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BLAC, ICU, LUCY, and CODX Company Descriptions

Bellevue Life Sciences Acquisition NASDAQ:BLAC

$0.60 -0.02 (-2.44%)

As of 08/8/2025

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Co-Diagnostics NASDAQ:CODX

$0.27 +0.00 (+0.91%)

Closing price 04:00 PM Eastern

Extended Trading

$0.27 +0.00 (+0.60%)

As of 04:19 PM Eastern

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

SeaStar Medical NASDAQ:ICU

$0.88 +0.15 (+20.98%)

Closing price 04:00 PM Eastern

Extended Trading

$0.90 +0.02 (+1.70%)

As of 04:18 PM Eastern

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

Innovative Eyewear NASDAQ:LUCY

$2.20 +0.20 (+10.00%)

Closing price 04:00 PM Eastern

Extended Trading

$2.15 -0.05 (-2.27%)

As of 04:18 PM Eastern

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time